Working… Menu

Bone Mineral Density in Postmenopausal Women at Increased Risk of Breast Cancer And Who Are Receiving Exemestane on MAP3

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00688246
Recruitment Status : Completed
First Posted : June 2, 2008
Last Update Posted : April 2, 2020
Information provided by (Responsible Party):
Canadian Cancer Trials Group ( NCIC Clinical Trials Group )

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : October 31, 2011
Actual Study Completion Date : January 10, 2013